17-34626169-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304438.2(TMEM132E):c.110C>T(p.Pro37Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000437 in 1,556,600 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304438.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM132E | NM_001304438.2 | c.110C>T | p.Pro37Leu | missense_variant | 2/9 | ENST00000631683.2 | NP_001291367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM132E | ENST00000631683.2 | c.110C>T | p.Pro37Leu | missense_variant | 2/9 | 5 | NM_001304438.2 | ENSP00000487800.2 | ||
TMEM132E | ENST00000321639.7 | c.110C>T | p.Pro37Leu | missense_variant | 2/10 | 5 | ENSP00000316532.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000611 AC: 10AN: 163550Hom.: 0 AF XY: 0.0000680 AC XY: 6AN XY: 88300
GnomAD4 exome AF: 0.0000456 AC: 64AN: 1404286Hom.: 1 Cov.: 32 AF XY: 0.0000476 AC XY: 33AN XY: 693046
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.110C>T (p.P37L) alteration is located in exon 2 (coding exon 2) of the TMEM132E gene. This alteration results from a C to T substitution at nucleotide position 110, causing the proline (P) at amino acid position 37 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at